Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2008 Sep 23;179(7):678. doi: 10.1503/cmaj.081363

Corrections

PMCID: PMC2535732

A news story about Health Canada's investment in a new post-market drug surveillance network that was published online at www.cmaj.ca on July 16, 2008, and in the August 26 print issue should have stated that rofecoxib (Vioxx) was withdrawn from the Canadian market in 2004.1

REFERENCE

  • 1.Silversides, A. Health Canada's investment in new post-market drug surveillance network a “pittance.” CMAJ 2008;179:412-3. [DOI] [PMC free article] [PubMed]

Articles from CMAJ : Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES